VKTX

32.65

0.28% 0.09

Dopo l'orario di chiusura: 32.85 0.20 +0.61%

Viking Therapeutics Inc (VKTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché VKTX Giù? Forum Previsione

Precedente Chiudi:

$32.56

Aprire:

$32.94

Volume 24 ore:

4.36M

Relative Volume:

1.00

Capitalizzazione di mercato:

$3.64B

Reddito:

Utile/perdita netta:

$-99.15M

Rapporto P/E:

-35.11

EPS:

-0.93

Flusso di cassa netto:

$-74.25M

1 W Prestazione:

-16.94%

1M Prestazione:

-30.09%

6M Prestazione:

-34.49%

1 anno Prestazione:

+52.43%

Intervallo 1D:

$32.56

$34.24

Intervallo di 1 settimana:

$32.51

$39.40

Portata 52W:

$20.47

$99.41

Viking Therapeutics Inc Stock (VKTX) Company Profile

Nome

Viking Therapeutics Inc

Settore

Healthcare (1174)

Industria

Biotechnology (684)

Telefono

858-704-4660

Indirizzo

9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA

Dipendente

Cinguettio

@viking_vktx

Prossima data di guadagno

2024-10-23

Ultimi documenti SEC

VKTX's Discussions on Twitter

Confronta VKTX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VKTX Viking Therapeutics Inc	32.65	3.64B	0	-99.15M	-74.25M	-0.93
VRTX Vertex Pharmaceuticals Inc	422.00	108.68B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	681.58	74.90B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	640.52	38.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	246.27	31.76B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	111.93	26.83B	3.30B	-501.07M	1.03B	-2.1146

Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-02	Iniziato	Piper Sandler	Overweight
2024-11-22	Iniziato	B. Riley Securities	Buy
2024-11-04	Reiterato	H.C. Wainwright	Buy
2024-09-11	Iniziato	JP Morgan	Overweight
2024-06-27	Iniziato	Morgan Stanley	Overweight
2024-05-16	Aggiornamento	Raymond James	Outperform → Strong Buy
2024-03-26	Reiterato	Oppenheimer	Outperform
2024-03-07	Iniziato	Jefferies	Buy
2024-02-28	Reiterato	Oppenheimer	Outperform
2023-05-31	Ripresa	ROTH MKM	Buy
2023-03-28	Reiterato	Maxim Group	Buy
2023-03-17	Iniziato	Stifel	Buy
2021-07-29	Ripresa	BTIG Research	Buy
2021-05-25	Downgrade	Raymond James	Strong Buy → Outperform
2020-06-05	Iniziato	BMO Capital Markets	Outperform
2020-05-05	Iniziato	Chardan Capital Markets	Buy
2020-05-01	Iniziato	BTIG Research	Buy
2019-07-16	Iniziato	Oppenheimer	Outperform
2019-06-25	Iniziato	Stifel	Buy
2019-03-29	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2019-03-14	Reiterato	Maxim Group	Buy
2019-02-22	Iniziato	SVB Leerink	Mkt Perform
2018-12-12	Iniziato	B. Riley FBR	Buy
2018-11-19	Aggiornamento	Raymond James	Outperform → Strong Buy
2018-09-18	Reiterato	H.C. Wainwright	Buy
2018-09-18	Reiterato	Maxim Group	Buy
2018-09-18	Reiterato	Raymond James	Outperform
2018-07-20	Iniziato	SunTrust	Buy
2018-06-28	Iniziato	Raymond James	Outperform
2018-06-01	Reiterato	Laidlaw	Buy
2018-05-31	Reiterato	Maxim Group	Buy
2018-03-26	Ripresa	H.C. Wainwright	Buy
2017-11-28	Reiterato	Maxim Group	Buy
2017-11-21	Iniziato	ROTH Capital	Buy

Mostra tutto

Viking Therapeutics Inc Borsa (VKTX) Ultime notizie

02:34 AM

Viking Therapeutics: The Turning Point Is Not Here Yet - Seeking Alpha

02:34 AM

09:56 AM

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? - Zacks Investment Research

09:56 AM

02:00 AM

Shelton Wealth Management LLC Purchases New Stake in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat

Jan 19, 2025

Jan 18, 2025

Viking Therapeutics (NASDAQ:VKTX) Receives "Buy" Rating from HC Wainwright - MarketBeat

Jan 18, 2025

Jan 17, 2025

12 Biotech Stocks with the Biggest Upside Potential - Insider Monkey

Jan 17, 2025

Viking Therapeutics (NASDAQ:VKTX) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Jan 17, 2025

Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today - sharewise

Jan 17, 2025

Viking Therapeutics (NASDAQ:VKTX) Trading Down 4.8%Here's What Happened - MarketBeat

Jan 17, 2025

Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs - AOL

Jan 17, 2025

Why Viking Therapeutics (VKTX) Is the Biotech Stock with Biggest Upside Potential - MSN

Jan 17, 2025

We Asked Retail How Viking Therapeutics Can Restore Investor Confidence: Majority Say Pursue Buyout Talks - MSN

Jan 17, 2025

Jan 16, 2025

Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today - Benzinga

Jan 16, 2025

Jan 15, 2025

NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow Down - Yahoo Finance

Jan 15, 2025

Jan 14, 2025

Viking Therapeutics posts positive results for oral weight-loss drug. Analysts remain unanimous the stock’s a buy. - MSN

Jan 14, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc.VKTX - PR Newswire

Jan 14, 2025

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday - MSN

Jan 14, 2025

Viking Therapeutics Becomes Oversold (VKTX) - Nasdaq

Jan 14, 2025

Jan 13, 2025